Clinical Trial 2927

Kettering, OH 45429

Study Summary:

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of LibiGel for the Treatment of HSDD in Surgically Menopausal Women.

Qualified Participants Must:

• Be female
• Be between 30 – 65 years of age
• Have a total hysterectomy including ovaries removed
• Be on hormone replacement therapy
• Not be taking any antidepressants

Qualified Participants May Receive:

Qualified patients will receive all study-related evaluations, laboratory tests, and study drug will be provided at no cost to you.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.